Curis
CRIS
#10265
Rank
A$31.95 M
Marketcap
A$0.80
Share price
-6.28%
Change (1 day)
-65.87%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): A-$5.79

According to Curis's latest financial reports the company's current EPS (TTM) is A-$5.15. In 2024 the company made an earnings per share (EPS) of A-$9.86 an increase over its 2023 EPS that were of A-$12.66.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$5.79-41.3%
2024A-$9.86-22.15%
2023A-$12.66-26.17%
2022A-$17.1522.3%
2021A-$14.02-25.37%
2020A-$18.79-30.93%
2019A-$27.21-2.02%
2018A-$27.77
2016A-$63.11-10%
2015A-$70.12138.1%
2014A-$29.4540%
2013A-$21.04-25%
2012A-$28.0566.67%
2011A-$16.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.91-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.85-194.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.50-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$4.05-178.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$5.46 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A-$15.76 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$1.98-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA